Cargando…

A decade of anti-IL-1 therapy in CAPS - a spectrum of efficacy in this spectrum of diseases

Detalles Bibliográficos
Autores principales:	Lane, T, Williams, RG, Rowczenio, DM, Youngstein, T, Trojer, H, Pepper, RJ, Brogan, PA, Hawkins, PN, Lachmann, HJ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596976/ http://dx.doi.org/10.1186/1546-0096-13-S1-O65

Ejemplares similares

PW03-020 – A decade of ANTI-IL-1 therpay for CAPS in the UK
por: Lane, T, et al.
Publicado: (2013)

First case of somatic mosaicism in TRAPS caused by a novel 24 nucleotides deletion in the TNFRSF1A gene
por: Rowczenio, D, et al.
Publicado: (2015)

Empirical use of anakinra in AA amyloidosis of uncertain aetiology
por: Lane, T, et al.
Publicado: (2015)

P02-010 - A novel 24 nucleotide deletion in the TNFRSF1A
por: Rowczenio, DM, et al.
Publicado: (2013)

Adult PFAPA - a single centre experience
por: Donnelly, O, et al.
Publicado: (2015)

Deletion in MEFV resulting in the loss of p.M694 residue as the cause of autosomal dominant familial Mediterranean fever in North Western European Caucasians - a case series and genetic exploration
por: Rowczenio, D, et al.
Publicado: (2015)

OR14-002 - ANTI IL-1 therapies and pregnancy outcome
por: Lachmann, HJ, et al.
Publicado: (2013)

P03-017 - Health related quality of life in adult with HRFS
por: Lachmann, HJ, et al.
Publicado: (2013)

International experience of pregnancy outcomes in auto-inflammatory syndromes treated with Interleukin-1 inhibitors
por: Youngstein, T, et al.
Publicado: (2015)

PW02-014 - Long term outcome and quality of life in TRAPS
por: Lane, T, et al.
Publicado: (2013)

PW02-030 - Clinical phenotype in individuals with Q703K
por: Rowczenio, DM, et al.
Publicado: (2013)

PW02-015 - Eight years HPFS experience in a single UK centre
por: Rowczenio, DM, et al.
Publicado: (2013)

PW01-021 – The phenotype of FMF due to deletion M694
por: Lachmann, HJ, et al.
Publicado: (2013)

Clinical symptoms and molecular investigations in 13 patients with Schnitzler syndrome identified at the single UK centre
por: Rowczenio, D, et al.
Publicado: (2015)

Late onset of the cryopyrin-associated periodic syndrome (CAPS) associated with low level of somatic mosaicism in six patients
por: Rowczenio, D, et al.
Publicado: (2015)

Diagnostic value of fat aspirates for amyloidosis in 950 patients
por: Gilbertson, JA, et al.
Publicado: (2015)

Calprotectin (S100A8/A9) in Familial Mediterranean Fever
por: Pepper, R, et al.
Publicado: (2015)

Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature syndrome: a report of a novel mutation and review of the literature
por: Kluk, J, et al.
Publicado: (2014)

Spectrum of adverse cutaneous eruptions to nevirapine – a cross sectional study
por: Budamakuntla, Leelavathy, et al.
Publicado: (2012)

OR14-001 – Tocilizumab in autoinflammation and AA amyloidosis
por: Lane, T, et al.
Publicado: (2013)

Pharmacokinetics of Canakinumab in children younger than 2 years old with CAPS
por: Kalabus, J, et al.
Publicado: (2015)

Neurology of the Cryopyrin-Associated Periodic Feversyndrome
por: Parker, T, et al.
Publicado: (2015)

Genotype-phenotype: correlations and emerging spectrum
por: Reuser, Arnold
Publicado: (2013)

The clinical spectrum of HTLV-1 infection
por: Tanajura, Davi, et al.
Publicado: (2015)

Identification of a novel monogenic autoinflammatory disease due to mutation in a mitochondrial chaperone protein in a single kindred, and cure with allogeneic haematopoietic stem cell transplantation
por: Standing, Ariane, et al.
Publicado: (2014)

Loss of function mutation in a mitochondrial chaperone protein leading to dyregulated ROS production, and autoinflammatory disease in a single kindred
por: Standing, A, et al.
Publicado: (2015)

Genetics of autism spectrum disorder & BDNF gene
por: Dave, Usha P
Publicado: (2014)

In the era of broad spectrum antibiotics, is ampicillin still an option?
por: Popescu, Cristina, et al.
Publicado: (2013)

9.3 Endothelial progenitor cells and vasculogenic responses to therapy in children with primary systemic vasculitis
por: Clarke, LA, et al.
Publicado: (2008)

Update of Emerinopathies’ clinical-genetic spectrum: the French network experience
por: Leturcq, France, et al.
Publicado: (2015)

O065 Autonomic Dysregulation During Sleep in Parkinsonian Spectrum Disorders
por: Levendowski, D, et al.
Publicado: (2023)

14.1 Clinical spectrum and outcome in 100 children with positive antiphospholipid antibodies
por: Rozic, M, et al.
Publicado: (2008)

Clinical and mutational spectrum of patients with congenital lipoid adrenal hyperplasia in Southeast Asia
por: Ariyawatkul, Kansuda, et al.
Publicado: (2015)

OA02 Paediatric chronic pain and Autism Spectrum Disorder: is there a link?
por: Jones, Gabriella, et al.
Publicado: (2022)

Diflunisal therapy for cardiac ATTR amyloidosis: a longitudinal, prospective, single centre study
por: Quarta, Candida C, et al.
Publicado: (2015)

P114 Clinical and microbiological spectrum of dermatophytosis from a tertiary care institute
por: Sudhaharan, Sukanya, et al.
Publicado: (2022)

PReS-FINAL-2187: Use of screening tests in patients presenting to paediatric rheumatology with suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome
por: Cruikshank, M, et al.
Publicado: (2013)

Shape and weight concern as a moderator of program outcomes from the Prevention Across the Spectrum RCT
por: Wilksch, Simon, et al.
Publicado: (2015)

P393 Clinical spectrum and molecular characterization of Rhytidhysteron spp. (now Gloniopsis) from India
por: Ahmad, Haseen, et al.
Publicado: (2022)

O-6 A muscle biopsy study in patients with Autism spectrum disorders and neuromuscular clinical signs
por: Scuderi, C., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_lpbd8a151osvirqhcq5qg429hu